Ignite Creation Date:
2024-05-05 @ 5:19 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00430963
Status:
COMPLETED
Last Update Posted:
2011-10-26
First Post:
2007-02-01
Brief Title:
IncobotulinumtoxinA Xeomin Versus Placebo in the Treatment of Glabellar Frown Lines
Sponsor:
Merz Pharmaceuticals GmbH
Organization:
Merz Pharmaceuticals GmbH
Organization Data
Organization:
Merz Pharmaceuticals GmbH
Class:
INDUSTRY
Study ID:
MRZ 60201-05201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Merz Pharmaceuticals GmbH
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None